MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (814)	5/4/2004 1:31:56 PM
From: Icebrg	Read Replies (1) of 2240

COPENHAGEN, Denmark, May 4 /PRNewswire-FirstCall/ -- Genmab A/S (CSE: GEN) announced today that it will participate in the Merrill Lynch Mid-Cap Biotech, Medtech & Pharmaceutical Conference in London on May 10. The conference will provide a forum for smaller companies and healthcare investors to meet through selected company presentations and one-on-one meetings. The conference will take place at the Merrill Lynch Financial Centre, 2 King Edward Street, London on May 10-11, 2004. "Genmab's participation in this conference will assist us in communicating our recent accomplishments, including the results of the HuMax-CD4 Phase II studies in cutaneous T-cell lymphoma and the positive HuMax-IL15 Phase II results, to investors," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next